Abbott Cardiovascular, headquartered in the United States, is a leading medical device company specializing in cardiovascular care. Founded in 1888 by Dr. Wallace Abbott, the company initially focused on developing pharmaceutical products.

Over the years, Abbott expanded its portfolio and ventured into various sectors, including cardiovascular devices. The company's headquarters are located in Abbott Park, Illinois. This state-of-the-art facility serves as a hub for research, development, and manufacturing activities.

Its strategic location allows close collaboration with leading research institutions and healthcare centers. Abbott Cardiovascular offers a range of products and services to manage cardiovascular diseases. Their flagship product is the Xience drug-eluting stent, which helps to open blocked arteries, improving blood flow to the heart.

In addition to stents, Abbott provides advanced diagnostic tools, such as intravascular imaging systems and pressure wires, to assess heart health. The company also offers surgical valve replacement and repair solutions. With a strong global presence, Abbott Cardiovascular has established subsidiaries, joint ventures, and partnerships around the world.

Notably, they have joined forces with St. Jude Medical to enhance their cardiovascular product portfolio. The acquisition of Thoratec Corporation has further strengthened Abbott's position in the heart failure market.

In terms of market position, Abbott Cardiovascular is a key player in the global cardiovascular devices market. It competes with industry giants like Medtronic and Boston Scientific. With a focus on innovation and patient outcomes, Abbott has gained a competitive advantage and maintained a significant market share.

Its global sales and revenue continue to grow, reinforcing its position as a trusted cardiovascular care partner. In recent years, Abbott announced major breakthroughs, including the approval of their next-generation Xience Sierra stent. This advanced device offers improved clinical performance and faster recovery for patients.

The company has also expanded its product lineup by introducing innovative heart valve solutions. As of the latest updates, Abbott Cardiovascular remains at the forefront of cardiovascular innovation. With ongoing research and development efforts, the company strives to address the unmet needs of patients worldwide.

By leveraging its global network of healthcare professionals and cutting-edge technologies, Abbott Cardiovascular continues to shape the future of cardiovascular care